HEADER HYDROLASE 17-AUG-06 2I3C TITLE CRYSTAL STRUCTURE OF AN ASPARTOACYLASE FROM HOMO SAPIENS COMPND MOL_ID: 1; COMPND 2 MOLECULE: ASPARTOACYLASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: AMINOACYLASE-2, ACY-2; COMPND 5 EC: 3.5.1.15; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ASPA, ACY2, ASP; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL834 P(RARE2); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PVP 33K KEYWDS CANAVAN DISEASE, N-ACETYL-L-ASPARTATE, ZINC-DEPENDENT HYDROLASE, KEYWDS 2 ASPARTOACYLASE FAMILY, AMINOACYLASE-2, ACY2, ASPA, PROTEIN STRUCTURE KEYWDS 3 INITIATIVE, PSI, CENTER FOR EUKARYOTIC STRUCTURAL GENOMICS, CESG, KEYWDS 4 HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR E.BITTO,G.E.WESENBERG,G.N.PHILLIPS JR.,J.G.MCCOY,C.A.BINGMAN,CENTER AUTHOR 2 FOR EUKARYOTIC STRUCTURAL GENOMICS (CESG) REVDAT 6 18-OCT-17 2I3C 1 REMARK REVDAT 5 24-FEB-09 2I3C 1 VERSN REVDAT 4 16-JAN-07 2I3C 1 JRNL REVDAT 3 09-JAN-07 2I3C 1 JRNL REVDAT 2 12-DEC-06 2I3C 1 JRNL REVDAT 1 29-AUG-06 2I3C 0 JRNL AUTH E.BITTO,C.A.BINGMAN,G.E.WESENBERG,J.G.MCCOY,G.N.PHILLIPS JRNL TITL STRUCTURE OF ASPARTOACYLASE, THE BRAIN ENZYME IMPAIRED IN JRNL TITL 2 CANAVAN DISEASE. JRNL REF PROC.NATL.ACAD.SCI.USA V. 104 456 2007 JRNL REFN ISSN 0027-8424 JRNL PMID 17194761 JRNL DOI 10.1073/PNAS.0607817104 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.72 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 3 NUMBER OF REFLECTIONS : 27305 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.197 REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.243 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.032 REMARK 3 FREE R VALUE TEST SET COUNT : 1374 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.87 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1502 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 78.93 REMARK 3 BIN R VALUE (WORKING SET) : 0.3540 REMARK 3 BIN FREE R VALUE SET COUNT : 90 REMARK 3 BIN FREE R VALUE : 0.4190 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4860 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 36 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 47.68 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.56700 REMARK 3 B22 (A**2) : 0.56700 REMARK 3 B33 (A**2) : -1.13300 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.501 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.305 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.217 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 23.555 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.933 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.899 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5014 ; 0.016 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6800 ; 1.551 ; 1.972 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 602 ; 6.237 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 236 ;38.426 ;24.492 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 874 ;18.843 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 24 ;22.202 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 738 ; 0.099 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3788 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2122 ; 0.229 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 3395 ; 0.321 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 113 ; 0.123 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): 6 ; 0.214 ; 0.200 REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 28 ; 0.193 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3094 ; 1.399 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4914 ; 2.415 ; 4.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2142 ; 4.441 ; 6.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1886 ; 6.166 ; 8.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 9 A 310 2 REMARK 3 1 B 9 B 310 2 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 TIGHT POSITIONAL 1 A (A): 1208 ; 0.050 ; 0.050 REMARK 3 MEDIUM POSITIONAL 1 A (A): 1222 ; 0.400 ; 0.500 REMARK 3 TIGHT THERMAL 1 A (A**2): 1208 ; 0.110 ; 0.500 REMARK 3 MEDIUM THERMAL 1 A (A**2): 1222 ; 0.950 ; 2.000 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK BULK SOLVENT REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2I3C COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-AUG-06. REMARK 100 THE DEPOSITION ID IS D_1000039084. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-AUG-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97926 REMARK 200 MONOCHROMATOR : CRYOGENICALLY COOLED SI (220) REMARK 200 DOUBLE BOUNCE REMARK 200 OPTICS : HORIZONTAL SAGITALLY FOCUSING REMARK 200 2ND BENT MONOCHROMATOR CRYSTAL, REMARK 200 VERTICAL BENT FOCUSING MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27367 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 48.716 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 200 DATA REDUNDANCY : 13.30 REMARK 200 R MERGE (I) : 0.16400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.6120 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 81.4 REMARK 200 DATA REDUNDANCY IN SHELL : 6.20 REMARK 200 R MERGE FOR SHELL (I) : 0.58200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.866 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2GU2 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 67.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.80 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN SOLUTION (10 MG/ML PROTEIN, REMARK 280 0.050 M SODIUM CHLORIDE, 0.0003 M TCEP, 0.005 M TRIS PH 8.0) REMARK 280 MIXED IN A 1:1 RATIO WITH THE WELL SOLUTION (1.344 M K2HPO4, REMARK 280 0.056 M NAH2PO4) CRYOPROTECTED WITH WELL SOLUTION WITH 25% REMARK 280 ETHYLENE GLYCOL, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 42 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y+1/2,X+1/2,Z+1/2 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/2 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 72.77550 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 72.77550 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 51.69800 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 72.77550 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 72.77550 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 51.69800 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 72.77550 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 72.77550 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 51.69800 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 72.77550 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 72.77550 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 51.69800 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL UNIT IS A DIMER (CHAINS A & B IN ASU). REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4500 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25860 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -150.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A -1 REMARK 465 ILE A 0 REMARK 465 ALA A 1 REMARK 465 THR A 2 REMARK 465 SER A 3 REMARK 465 CYS A 4 REMARK 465 HIS A 5 REMARK 465 ILE A 6 REMARK 465 ALA A 7 REMARK 465 GLU A 8 REMARK 465 CYS A 311 REMARK 465 LEU A 312 REMARK 465 HIS A 313 REMARK 465 ALA B -1 REMARK 465 ILE B 0 REMARK 465 ALA B 1 REMARK 465 THR B 2 REMARK 465 SER B 3 REMARK 465 CYS B 4 REMARK 465 HIS B 5 REMARK 465 ILE B 6 REMARK 465 ALA B 7 REMARK 465 GLU B 8 REMARK 465 CYS B 311 REMARK 465 LEU B 312 REMARK 465 HIS B 313 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 87 134.54 -39.50 REMARK 500 ASP A 104 -8.44 77.59 REMARK 500 ASN A 133 82.21 -153.21 REMARK 500 TRP A 252 -25.36 76.21 REMARK 500 MSE A 261 -44.28 -132.41 REMARK 500 ASP A 275 52.53 -145.69 REMARK 500 LYS A 291 32.33 -66.35 REMARK 500 LYS A 292 72.14 30.96 REMARK 500 ILE B 65 -65.65 -90.25 REMARK 500 ASP B 104 -0.70 77.31 REMARK 500 ASN B 133 82.37 -158.59 REMARK 500 ASP B 234 -169.99 -103.91 REMARK 500 TRP B 252 -25.44 76.47 REMARK 500 MSE B 261 -48.41 -134.58 REMARK 500 ASP B 266 2.99 -68.19 REMARK 500 ASP B 275 47.13 -140.93 REMARK 500 ASN B 284 48.64 72.24 REMARK 500 TYR B 289 -70.36 -66.14 REMARK 500 LYS B 291 40.25 -68.43 REMARK 500 LYS B 292 76.07 23.49 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 314 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 21 ND1 REMARK 620 2 PO4 A 315 O2 117.2 REMARK 620 3 GLU A 24 OE2 84.4 112.8 REMARK 620 4 GLU A 24 OE1 126.2 113.6 59.9 REMARK 620 5 HIS A 116 ND1 108.7 86.1 149.6 91.2 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 314 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU B 24 OE2 REMARK 620 2 HIS B 116 ND1 137.9 REMARK 620 3 PO4 B 315 O3 113.6 98.9 REMARK 620 4 GLU B 24 OE1 54.7 87.2 117.4 REMARK 620 5 HIS B 21 ND1 89.1 102.2 113.4 126.0 REMARK 620 N 1 2 3 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 314 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 314 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 315 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 316 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 B 315 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 B 316 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 B 317 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 317 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 B 318 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 318 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2GU2 RELATED DB: PDB REMARK 900 ASPARTOACYLASE FROM RAT REMARK 900 RELATED ID: GO.79368 RELATED DB: TARGETDB DBREF 2I3C A 2 313 UNP P45381 ACY2_HUMAN 2 313 DBREF 2I3C B 2 313 UNP P45381 ACY2_HUMAN 2 313 SEQADV 2I3C ALA A -1 UNP P45381 CLONING ARTIFACT SEQADV 2I3C ILE A 0 UNP P45381 CLONING ARTIFACT SEQADV 2I3C ALA A 1 UNP P45381 CLONING ARTIFACT SEQADV 2I3C MSE A 82 UNP P45381 MET 82 MODIFIED RESIDUE SEQADV 2I3C MSE A 122 UNP P45381 MET 122 MODIFIED RESIDUE SEQADV 2I3C MSE A 139 UNP P45381 MET 139 MODIFIED RESIDUE SEQADV 2I3C MSE A 195 UNP P45381 MET 195 MODIFIED RESIDUE SEQADV 2I3C MSE A 198 UNP P45381 MET 198 MODIFIED RESIDUE SEQADV 2I3C MSE A 261 UNP P45381 MET 261 MODIFIED RESIDUE SEQADV 2I3C ALA B -1 UNP P45381 CLONING ARTIFACT SEQADV 2I3C ILE B 0 UNP P45381 CLONING ARTIFACT SEQADV 2I3C ALA B 1 UNP P45381 CLONING ARTIFACT SEQADV 2I3C MSE B 82 UNP P45381 MET 82 MODIFIED RESIDUE SEQADV 2I3C MSE B 122 UNP P45381 MET 122 MODIFIED RESIDUE SEQADV 2I3C MSE B 139 UNP P45381 MET 139 MODIFIED RESIDUE SEQADV 2I3C MSE B 195 UNP P45381 MET 195 MODIFIED RESIDUE SEQADV 2I3C MSE B 198 UNP P45381 MET 198 MODIFIED RESIDUE SEQADV 2I3C MSE B 261 UNP P45381 MET 261 MODIFIED RESIDUE SEQRES 1 A 315 ALA ILE ALA THR SER CYS HIS ILE ALA GLU GLU HIS ILE SEQRES 2 A 315 GLN LYS VAL ALA ILE PHE GLY GLY THR HIS GLY ASN GLU SEQRES 3 A 315 LEU THR GLY VAL PHE LEU VAL LYS HIS TRP LEU GLU ASN SEQRES 4 A 315 GLY ALA GLU ILE GLN ARG THR GLY LEU GLU VAL LYS PRO SEQRES 5 A 315 PHE ILE THR ASN PRO ARG ALA VAL LYS LYS CYS THR ARG SEQRES 6 A 315 TYR ILE ASP CYS ASP LEU ASN ARG ILE PHE ASP LEU GLU SEQRES 7 A 315 ASN LEU GLY LYS LYS MSE SER GLU ASP LEU PRO TYR GLU SEQRES 8 A 315 VAL ARG ARG ALA GLN GLU ILE ASN HIS LEU PHE GLY PRO SEQRES 9 A 315 LYS ASP SER GLU ASP SER TYR ASP ILE ILE PHE ASP LEU SEQRES 10 A 315 HIS ASN THR THR SER ASN MSE GLY CYS THR LEU ILE LEU SEQRES 11 A 315 GLU ASP SER ARG ASN ASN PHE LEU ILE GLN MSE PHE HIS SEQRES 12 A 315 TYR ILE LYS THR SER LEU ALA PRO LEU PRO CYS TYR VAL SEQRES 13 A 315 TYR LEU ILE GLU HIS PRO SER LEU LYS TYR ALA THR THR SEQRES 14 A 315 ARG SER ILE ALA LYS TYR PRO VAL GLY ILE GLU VAL GLY SEQRES 15 A 315 PRO GLN PRO GLN GLY VAL LEU ARG ALA ASP ILE LEU ASP SEQRES 16 A 315 GLN MSE ARG LYS MSE ILE LYS HIS ALA LEU ASP PHE ILE SEQRES 17 A 315 HIS HIS PHE ASN GLU GLY LYS GLU PHE PRO PRO CYS ALA SEQRES 18 A 315 ILE GLU VAL TYR LYS ILE ILE GLU LYS VAL ASP TYR PRO SEQRES 19 A 315 ARG ASP GLU ASN GLY GLU ILE ALA ALA ILE ILE HIS PRO SEQRES 20 A 315 ASN LEU GLN ASP GLN ASP TRP LYS PRO LEU HIS PRO GLY SEQRES 21 A 315 ASP PRO MSE PHE LEU THR LEU ASP GLY LYS THR ILE PRO SEQRES 22 A 315 LEU GLY GLY ASP CYS THR VAL TYR PRO VAL PHE VAL ASN SEQRES 23 A 315 GLU ALA ALA TYR TYR GLU LYS LYS GLU ALA PHE ALA LYS SEQRES 24 A 315 THR THR LYS LEU THR LEU ASN ALA LYS SER ILE ARG CYS SEQRES 25 A 315 CYS LEU HIS SEQRES 1 B 315 ALA ILE ALA THR SER CYS HIS ILE ALA GLU GLU HIS ILE SEQRES 2 B 315 GLN LYS VAL ALA ILE PHE GLY GLY THR HIS GLY ASN GLU SEQRES 3 B 315 LEU THR GLY VAL PHE LEU VAL LYS HIS TRP LEU GLU ASN SEQRES 4 B 315 GLY ALA GLU ILE GLN ARG THR GLY LEU GLU VAL LYS PRO SEQRES 5 B 315 PHE ILE THR ASN PRO ARG ALA VAL LYS LYS CYS THR ARG SEQRES 6 B 315 TYR ILE ASP CYS ASP LEU ASN ARG ILE PHE ASP LEU GLU SEQRES 7 B 315 ASN LEU GLY LYS LYS MSE SER GLU ASP LEU PRO TYR GLU SEQRES 8 B 315 VAL ARG ARG ALA GLN GLU ILE ASN HIS LEU PHE GLY PRO SEQRES 9 B 315 LYS ASP SER GLU ASP SER TYR ASP ILE ILE PHE ASP LEU SEQRES 10 B 315 HIS ASN THR THR SER ASN MSE GLY CYS THR LEU ILE LEU SEQRES 11 B 315 GLU ASP SER ARG ASN ASN PHE LEU ILE GLN MSE PHE HIS SEQRES 12 B 315 TYR ILE LYS THR SER LEU ALA PRO LEU PRO CYS TYR VAL SEQRES 13 B 315 TYR LEU ILE GLU HIS PRO SER LEU LYS TYR ALA THR THR SEQRES 14 B 315 ARG SER ILE ALA LYS TYR PRO VAL GLY ILE GLU VAL GLY SEQRES 15 B 315 PRO GLN PRO GLN GLY VAL LEU ARG ALA ASP ILE LEU ASP SEQRES 16 B 315 GLN MSE ARG LYS MSE ILE LYS HIS ALA LEU ASP PHE ILE SEQRES 17 B 315 HIS HIS PHE ASN GLU GLY LYS GLU PHE PRO PRO CYS ALA SEQRES 18 B 315 ILE GLU VAL TYR LYS ILE ILE GLU LYS VAL ASP TYR PRO SEQRES 19 B 315 ARG ASP GLU ASN GLY GLU ILE ALA ALA ILE ILE HIS PRO SEQRES 20 B 315 ASN LEU GLN ASP GLN ASP TRP LYS PRO LEU HIS PRO GLY SEQRES 21 B 315 ASP PRO MSE PHE LEU THR LEU ASP GLY LYS THR ILE PRO SEQRES 22 B 315 LEU GLY GLY ASP CYS THR VAL TYR PRO VAL PHE VAL ASN SEQRES 23 B 315 GLU ALA ALA TYR TYR GLU LYS LYS GLU ALA PHE ALA LYS SEQRES 24 B 315 THR THR LYS LEU THR LEU ASN ALA LYS SER ILE ARG CYS SEQRES 25 B 315 CYS LEU HIS MODRES 2I3C MSE A 82 MET SELENOMETHIONINE MODRES 2I3C MSE A 122 MET SELENOMETHIONINE MODRES 2I3C MSE A 139 MET SELENOMETHIONINE MODRES 2I3C MSE A 195 MET SELENOMETHIONINE MODRES 2I3C MSE A 198 MET SELENOMETHIONINE MODRES 2I3C MSE A 261 MET SELENOMETHIONINE MODRES 2I3C MSE B 82 MET SELENOMETHIONINE MODRES 2I3C MSE B 122 MET SELENOMETHIONINE MODRES 2I3C MSE B 139 MET SELENOMETHIONINE MODRES 2I3C MSE B 195 MET SELENOMETHIONINE MODRES 2I3C MSE B 198 MET SELENOMETHIONINE MODRES 2I3C MSE B 261 MET SELENOMETHIONINE HET MSE A 82 8 HET MSE A 122 8 HET MSE A 139 8 HET MSE A 195 8 HET MSE A 198 8 HET MSE A 261 8 HET MSE B 82 8 HET MSE B 122 8 HET MSE B 139 8 HET MSE B 195 8 HET MSE B 198 8 HET MSE B 261 8 HET ZN A 314 1 HET PO4 A 315 5 HET PO4 A 316 5 HET PO4 A 317 5 HET PO4 A 318 5 HET ZN B 314 1 HET PO4 B 315 5 HET PO4 B 316 5 HET PO4 B 317 5 HET PO4 B 318 5 HETNAM MSE SELENOMETHIONINE HETNAM ZN ZINC ION HETNAM PO4 PHOSPHATE ION FORMUL 1 MSE 12(C5 H11 N O2 SE) FORMUL 3 ZN 2(ZN 2+) FORMUL 4 PO4 8(O4 P 3-) FORMUL 13 HOH *36(H2 O) HELIX 1 1 GLU A 24 LEU A 35 1 12 HELIX 2 2 GLY A 38 GLN A 42 5 5 HELIX 3 3 ASN A 54 LYS A 60 1 7 HELIX 4 4 ASP A 68 ILE A 72 5 5 HELIX 5 5 ASP A 74 GLY A 79 1 6 HELIX 6 6 PRO A 87 GLY A 101 1 15 HELIX 7 7 ASN A 133 ALA A 148 1 16 HELIX 8 8 THR A 166 ALA A 171 5 6 HELIX 9 9 ARG A 188 GLU A 211 1 24 HELIX 10 10 GLU A 285 TYR A 289 5 5 HELIX 11 11 GLU B 24 LEU B 35 1 12 HELIX 12 12 GLY B 38 GLN B 42 5 5 HELIX 13 13 ASN B 54 LYS B 60 1 7 HELIX 14 14 ASP B 68 ILE B 72 5 5 HELIX 15 15 ASP B 74 GLY B 79 1 6 HELIX 16 16 PRO B 87 GLY B 101 1 15 HELIX 17 17 ASN B 133 ALA B 148 1 16 HELIX 18 18 THR B 166 ALA B 171 5 6 HELIX 19 19 ARG B 188 GLU B 211 1 24 HELIX 20 20 GLU B 285 TYR B 289 5 5 SHEET 1 A 9 GLU A 47 ILE A 52 0 SHEET 2 A 9 LYS A 13 GLY A 18 1 N VAL A 14 O LYS A 49 SHEET 3 A 9 ILE A 111 ASN A 117 1 O PHE A 113 N PHE A 17 SHEET 4 A 9 TYR A 173 GLY A 180 1 O VAL A 175 N ILE A 112 SHEET 5 A 9 GLY A 123 LEU A 128 -1 N ILE A 127 O GLY A 176 SHEET 6 A 9 CYS A 152 LEU A 156 1 O TYR A 155 N LEU A 126 SHEET 7 A 9 CYS A 218 VAL A 229 1 O TYR A 223 N LEU A 156 SHEET 8 A 9 PHE A 295 ALA A 305 -1 O ALA A 305 N CYS A 218 SHEET 9 A 9 TYR A 279 VAL A 281 -1 N VAL A 281 O ALA A 296 SHEET 1 B 2 GLU A 214 PHE A 215 0 SHEET 2 B 2 ILE A 308 ARG A 309 -1 O ILE A 308 N PHE A 215 SHEET 1 C 3 ILE A 242 ILE A 243 0 SHEET 2 C 3 PRO A 260 LEU A 263 -1 O LEU A 263 N ILE A 242 SHEET 3 C 3 THR A 269 PRO A 271 -1 O ILE A 270 N PHE A 262 SHEET 1 D 9 GLU B 47 ILE B 52 0 SHEET 2 D 9 LYS B 13 GLY B 18 1 N VAL B 14 O LYS B 49 SHEET 3 D 9 ILE B 111 ASN B 117 1 O PHE B 113 N PHE B 17 SHEET 4 D 9 TYR B 173 GLY B 180 1 O VAL B 175 N ILE B 112 SHEET 5 D 9 GLY B 123 LEU B 128 -1 N ILE B 127 O GLY B 176 SHEET 6 D 9 CYS B 152 LEU B 156 1 O TYR B 155 N LEU B 126 SHEET 7 D 9 CYS B 218 VAL B 229 1 O TYR B 223 N LEU B 156 SHEET 8 D 9 PHE B 295 ALA B 305 -1 O LEU B 301 N VAL B 222 SHEET 9 D 9 TYR B 279 VAL B 281 -1 N VAL B 281 O ALA B 296 SHEET 1 E 3 ILE B 242 ILE B 243 0 SHEET 2 E 3 PRO B 260 LEU B 263 -1 O LEU B 263 N ILE B 242 SHEET 3 E 3 THR B 269 PRO B 271 -1 O ILE B 270 N PHE B 262 LINK C LYS A 81 N MSE A 82 1555 1555 1.32 LINK C MSE A 82 N SER A 83 1555 1555 1.33 LINK C ASN A 121 N MSE A 122 1555 1555 1.34 LINK C MSE A 122 N GLY A 123 1555 1555 1.33 LINK C GLN A 138 N MSE A 139 1555 1555 1.32 LINK C MSE A 139 N PHE A 140 1555 1555 1.32 LINK C GLN A 194 N MSE A 195 1555 1555 1.33 LINK C MSE A 195 N ARG A 196 1555 1555 1.33 LINK C LYS A 197 N MSE A 198 1555 1555 1.33 LINK C MSE A 198 N ILE A 199 1555 1555 1.33 LINK C PRO A 260 N MSE A 261 1555 1555 1.33 LINK C MSE A 261 N PHE A 262 1555 1555 1.33 LINK ZN ZN A 314 ND1 HIS A 21 1555 1555 1.95 LINK ZN ZN A 314 O2 PO4 A 315 1555 1555 1.81 LINK ZN ZN A 314 OE2 GLU A 24 1555 1555 2.40 LINK ZN ZN A 314 OE1 GLU A 24 1555 1555 1.93 LINK ZN ZN A 314 ND1 HIS A 116 1555 1555 2.08 LINK C LYS B 81 N MSE B 82 1555 1555 1.34 LINK C MSE B 82 N SER B 83 1555 1555 1.33 LINK C ASN B 121 N MSE B 122 1555 1555 1.34 LINK C MSE B 122 N GLY B 123 1555 1555 1.33 LINK C GLN B 138 N MSE B 139 1555 1555 1.33 LINK C MSE B 139 N PHE B 140 1555 1555 1.34 LINK C GLN B 194 N MSE B 195 1555 1555 1.33 LINK C MSE B 195 N ARG B 196 1555 1555 1.32 LINK C LYS B 197 N MSE B 198 1555 1555 1.33 LINK C MSE B 198 N ILE B 199 1555 1555 1.32 LINK C PRO B 260 N MSE B 261 1555 1555 1.32 LINK C MSE B 261 N PHE B 262 1555 1555 1.33 LINK ZN ZN B 314 OE2 GLU B 24 1555 1555 2.69 LINK ZN ZN B 314 ND1 HIS B 116 1555 1555 2.22 LINK ZN ZN B 314 O3 PO4 B 315 1555 1555 1.59 LINK ZN ZN B 314 OE1 GLU B 24 1555 1555 1.87 LINK ZN ZN B 314 ND1 HIS B 21 1555 1555 2.03 CISPEP 1 GLY A 101 PRO A 102 0 -10.67 CISPEP 2 ALA A 148 PRO A 149 0 14.54 CISPEP 3 GLY A 180 PRO A 181 0 2.88 CISPEP 4 GLY B 101 PRO B 102 0 -11.83 CISPEP 5 ALA B 148 PRO B 149 0 14.54 CISPEP 6 GLY B 180 PRO B 181 0 4.04 SITE 1 AC1 4 HIS A 21 GLU A 24 HIS A 116 PO4 A 315 SITE 1 AC2 4 HIS B 21 GLU B 24 HIS B 116 PO4 B 315 SITE 1 AC3 9 HIS A 21 GLU A 24 ARG A 63 HIS A 116 SITE 2 AC3 9 ASN A 117 GLU A 178 TYR A 288 ZN A 314 SITE 3 AC3 9 PO4 A 316 SITE 1 AC4 6 HIS A 21 ARG A 63 ASP A 68 ASN A 70 SITE 2 AC4 6 ARG A 71 PO4 A 315 SITE 1 AC5 9 HIS B 21 GLU B 24 ARG B 63 HIS B 116 SITE 2 AC5 9 ASN B 117 GLU B 178 TYR B 288 ZN B 314 SITE 3 AC5 9 PO4 B 316 SITE 1 AC6 8 HIS B 21 ARG B 63 ASP B 68 ASN B 70 SITE 2 AC6 8 ARG B 71 TYR B 288 LYS B 291 PO4 B 315 SITE 1 AC7 5 LYS B 103 ASP B 104 LEU B 162 LYS B 163 SITE 2 AC7 5 TYR B 164 SITE 1 AC8 4 LYS A 103 ASP A 104 HOH A 322 LYS B 163 SITE 1 AC9 2 HIS B 159 HOH B 329 SITE 1 BC1 3 ARG A 71 HIS A 159 LYS A 228 CRYST1 145.551 145.551 103.396 90.00 90.00 90.00 P 42 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006870 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006870 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009672 0.00000 MASTER 413 0 22 20 26 0 17 6 0 0 0 50 END